Asta Auerbach

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection

M. Ots-Rosenberg, Ž. Riispere, E. Seppet, 2017, BMC Nephrology.

IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.

M. Ots-Rosenberg, A. Laurinavičius, Ž. Riispere, 2016, Medicina.